Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In the LEADER trial, over 9,340 patients with type 2 diabetes and high cardiovascular disease risk underwent randomization to liraglutide or placebo and were followed for a median of 3.8 years resulting in a 13% risk reduction in a combined endpoint of death from cardiovascular cause, nonfatal myocardial infarction, or nonfatal stroke [46]
PMID: 220 DentSCortsJImYHDirasVHarbeckNKropIEet al
If you have questions about what water to use, such as if it is not indicated on the label, call your doctor
It is one of the most requested metabolic-research tool compounds we stock in the UK, used in in-vitro assay work by qualified researchers
US$ 23.24
US$ 29.30
US$ 28.72
